IP Library Granted Patent US 9,005,598
Granted Patent B2
US 9,005,598 · App. 13/254,003 · Granted Apr 14, 2015

Conjugated proteins and peptides

Inventors: Antony Robert Godwin (London, GB); Stephen James Brocchini (Hertfordshire, GB)
Assignee: Polytherics Limited
A61K47/48215
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,005,598
App. No.
13/254,003
Granted
Apr 14, 2015
Kind
B2
Abstract

Novel compounds of the general formula (I): in which X represents a polymer; Q represents a linking group; W represents an electron-withdrawing moiety or a moiety preparable by reduction of an electron-withdrawing moiety; each of R 1 and R 2 independently represents a hydrogen atom or a C 1-4 alkyl group; and either Z 1 represents a protein or a peptide linked to CR 2 via a nucleophilic moiety, and Z 2 represents a molecule linked to CR 2 via a nucleophilic moiety, or Z 1 and Z 2 together represent a single group derived from a protein or peptide linked to CR via two nucleophilic moieties.

Claims (30)

1. A compound of the general formula:

in which X represents a polymer;

Q represents a linking group;

W represents an electron-withdrawing moiety or a moiety preparable by reduction of an electron-withdrawing moiety;

each of R 1 and R 2 independently represents a hydrogen atom or a C 1-4 alkyl group; and

either Z 1 represents a protein or a peptide linked to CR 2 via a nucleophilic moiety, and

Z 2 represents a molecule linked to CR 2 via a nucleophilic moiety, or Z 1 and

Z 2 together represent a single group derived from a protein or peptide linked to CR 2 via two nucleophilic moieties.

2. A compound as claimed in claim 1 , in which X is a polyalkylene glycol, a polyvinylpyrrolidone, a polyacrylate, a polymethacrylate, a polyoxazoline, a polyvinylalcohol, a polyacrylamide or polymethacrylamide, a HPMA copolymer, a polyester, polyacetal, poly(ortho ester), polycarbonate, poly(imino carbonate), a polyamide, a copolymer derived from two or more alkylene oxides or from an alkylene oxide and a polyester, polyacetal, poly(ortho ester), or a poly(amino acid), a copolymer of divinylether-maleic anhydride and styrene-maleic anhydride, a polysaccharide, polyglutamic acid, or a copolymer of a saccharides or an amino acid with an alkylene oxide or methacrylic acid.

3. A compound as claimed in claim 1 , in which X is a water-soluble synthetic polymer.

4. A compound as claimed in claim 3 , in which X is a polyethylene glycol.

5. A compound as claimed in claim 1 , in which Q is a direct bond, an alkylene group, or an optionally-substituted aryl or heteroaryl group, any of which may be terminated or interrupted by one or more oxygen atoms, sulphur atoms, —NR groups in which R represents a hydrogen atom or an alkyl or aryl group, keto groups, —O—CO— groups and/or —CO—O— groups.

6. A compound as claimed in claim 5 , in which W represents a keto group CO, an ester group —O—CO—, an amide group —NH—CO—, or a sulphone group —SO 2 —, or a group obtained by reduction of such a group.

7. A compound as claimed in claim 1 , in which Z 1 and Z 2 together represent a single group derived from a protein.

8. A compound as claimed in claim 7 , in which Z 1 and Z 2 together form a single group derived from a protein which is linked to CR 2 via two thiol groups which have been derived from a disulfide bridge in the protein.

9. A compound as claimed in claim 7 , in which Z 1 and Z 2 together form a single group derived from a protein which is linked to CR 2 via two histidine residues.

10. A compound as claimed in claim 9 , in which said two histidine residues form part of a polyhistidine tag.

11. A compound of the general formula II:

X-Q-W′—CR 1 R 1 ′—CR 2 .L.L′  (II)

in which X represents a polymer;

Q represents a direct bond, an alkylene group, or an optionally-substituted aryl or heteroaryl group, any of which may be terminated or interrupted by one or more oxygen atoms, sulphur atoms, —NR— groups in which R represents a hydrogen atom or an alkyl or an aryl group, keto groups, —O—CO— groups and/or —CO—O— groups;

W′ represents an electron-withdrawing group;

either R 1 represents a hydrogen atom or a C 1-4 alkyl group, R 1′ represents a hydrogen atom, and each of L and L′ independently represents a leaving group; or

R 1 represents a hydrogen atom or a C 1-4 alkyl group, L represents a leaving group, and R 1 ′ and L′ together represent a bond; or

R 1 and L together represent a bond and R 1 ′ and L′ together represent a bond; and

R 2 represents a hydrogen atom or a C 1-4 alkyl group;

provided that when Q represents a direct bond, R 1 represents a hydrogen atom or a C 1-4 alkyl group.

12. A compound as claimed in claim 11 , in which a leaving group L or L′ represents —SR, —SO 2 R, —OSO 2 R, —N + R 3 , —N + HR 2 , —N + H 2 R, halogen, or —OØ, in which R represents a hydrogen atom or an alkyl or an aryl group, and Ø represents a substituted aryl group containing at least one electron-withdrawing substituent.

13. A compound as claimed in claim 11 , in which W′ represents a keto group, an ester group, an amide group, or a sulfone group.

14. A pharmaceutical composition comprising a compound as claimed in claim 1 together with a pharmaceutically acceptable carrier.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2011
From: GODWIN, ANTONY ROBERT; BROCCHINI, STEPHEN JAMES
To: POLYTHERICS LIMITED
Reel/Frame 027098/0133 →
Priority Claims (3)
GB 0903746.6 · Mar 4, 2009 · national
GB 0912485.0 · Jul 17, 2009 · national
GB 0922354.6 · Dec 21, 2009 · national
Continuity (1)
Related Publication 20120014905A1 · Jan 19, 2012